Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review
Kratom ( Mitragyna speciosa ) leaves contain the mu opioid partial agonists mitragynine and 7-hydroxymitragynine. The US Drug Enforcement Agency considers it a ‘drug of concern’, and the US FDA is reviewing kratom, but there is a paucity of information regarding health effects. Liver injury is often...
Saved in:
Published in | Drugs (New York, N.Y.) Vol. 80; no. 3; pp. 263 - 283 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.02.2020
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Kratom (
Mitragyna speciosa
) leaves contain the mu opioid partial agonists mitragynine and 7-hydroxymitragynine. The US Drug Enforcement Agency considers it a ‘drug of concern’, and the US FDA is reviewing kratom, but there is a paucity of information regarding health effects. Liver injury is often cited as a potential health consequence, however the same few case reports are repeatedly referenced, without a broader context. Furthermore, reports have largely lacked standardized causality assessment methods. The objective is to evaluate causality in kratom liver injury, through a comprehensive scoping review of human cases, and by reviewing epidemiologic, animal, and mechanistic reports that relate to kratom liver injury. Hepatotoxicity causality was systematically examined using the Roussel Uclaf Causality Assessment Method (RUCAM) for case reports. Biopsy findings, potential pathophysiologic mechanisms, and management options are discussed. This review identified 26 case reports and abstracts, in addition to 7 cases reported from the Drug-Induced Liver Injury Network, 25 in FDA databases, and 27 in internet user forums. Latency periods to symptom onset had a median of 20.6 days and mean of 21 days (range 2–49). Common presenting signs and symptoms were abdominal discomfort, jaundice, pruritis, and dark urine. Histologic findings were predominantly cholestatic, although, biochemically, the condition was heterogenous or mixed; the median R ratio was 3.4 and the mean was 4.6 (range 0.24–10.4). Kratom likely causes liver injury based on the totality of low-quality human evidence, and, in the context of epidemiologic, animal, and mechanistic studies. It remains unclear which subgroups of users are at heightened risk. |
---|---|
AbstractList | Kratom (Mitragyna speciosa) leaves contain the mu opioid partial agonists mitragynine and 7-hydroxymitragynine. The US Drug Enforcement Agency considers it a 'drug of concern', and the US FDA is reviewing kratom, but there is a paucity of information regarding health effects. Liver injury is often cited as a potential health consequence, however the same few case reports are repeatedly referenced, without a broader context. Furthermore, reports have largely lacked standardized causality assessment methods. The objective is to evaluate causality in kratom liver injury, through a comprehensive scoping review of human cases, and by reviewing epidemiologic, animal, and mechanistic reports that relate to kratom liver injury. Hepatotoxicity causality was systematically examined using the Roussel Uclaf Causality Assessment Method (RUCAM) for case reports. Biopsy findings, potential pathophysiologic mechanisms, and management options are discussed. This review identified 26 case reports and abstracts, in addition to 7 cases reported from the Drug-Induced Liver Injury Network, 25 in FDA databases, and 27 in internet user forums. Latency periods to symptom onset had a median of 20.6 days and mean of 21 days (range 2-49). Common presenting signs and symptoms were abdominal discomfort, jaundice, pruritis, and dark urine. Histologic findings were predominantly cholestatic, although, biochemically, the condition was heterogenous or mixed; the median R ratio was 3.4 and the mean was 4.6 (range 0.24-10.4). Kratom likely causes liver injury based on the totality of low-quality human evidence, and, in the context of epidemiologic, animal, and mechanistic studies. It remains unclear which subgroups of users are at heightened risk. Kratom (Mitragyna speciosa) leaves contain the mu opioid partial agonists mitragynine and 7-hydroxymitragynine. The US Drug Enforcement Agency considers it a 'drug of concern', and the US FDA is reviewing kratom, but there is a paucity of information regarding health effects. Liver injury is often cited as a potential health consequence, however the same few case reports are repeatedly referenced, without a broader context. Furthermore, reports have largely lacked standardized causality assessment methods. The objective is to evaluate causality in kratom liver injury, through a comprehensive scoping review of human cases, and by reviewing epidemiologic, animal, and mechanistic reports that relate to kratom liver injury. Hepatotoxicity causality was systematically examined using the Roussel Uclaf Causality Assessment Method (RUCAM) for case reports. Biopsy findings, potential pathophysiologic mechanisms, and management options are discussed. This review identified 26 case reports and abstracts, in addition to 7 cases reported from the Drug-Induced Liver Injury Network, 25 in FDA databases, and 27 in internet user forums. Latency periods to symptom onset had a median of 20.6 days and mean of 21 days (range 2-49). Common presenting signs and symptoms were abdominal discomfort, jaundice, pruritis, and dark urine. Histologic findings were predominantly cholestatic, although, biochemically, the condition was heterogenous or mixed; the median R ratio was 3.4 and the mean was 4.6 (range 0.24-10.4). Kratom likely causes liver injury based on the totality of low-quality human evidence, and, in the context of epidemiologic, animal, and mechanistic studies. It remains unclear which subgroups of users are at heightened risk. Kratom ( Mitragyna speciosa ) leaves contain the mu opioid partial agonists mitragynine and 7-hydroxymitragynine. The US Drug Enforcement Agency considers it a ‘drug of concern’, and the US FDA is reviewing kratom, but there is a paucity of information regarding health effects. Liver injury is often cited as a potential health consequence, however the same few case reports are repeatedly referenced, without a broader context. Furthermore, reports have largely lacked standardized causality assessment methods. The objective is to evaluate causality in kratom liver injury, through a comprehensive scoping review of human cases, and by reviewing epidemiologic, animal, and mechanistic reports that relate to kratom liver injury. Hepatotoxicity causality was systematically examined using the Roussel Uclaf Causality Assessment Method (RUCAM) for case reports. Biopsy findings, potential pathophysiologic mechanisms, and management options are discussed. This review identified 26 case reports and abstracts, in addition to 7 cases reported from the Drug-Induced Liver Injury Network, 25 in FDA databases, and 27 in internet user forums. Latency periods to symptom onset had a median of 20.6 days and mean of 21 days (range 2–49). Common presenting signs and symptoms were abdominal discomfort, jaundice, pruritis, and dark urine. Histologic findings were predominantly cholestatic, although, biochemically, the condition was heterogenous or mixed; the median R ratio was 3.4 and the mean was 4.6 (range 0.24–10.4). Kratom likely causes liver injury based on the totality of low-quality human evidence, and, in the context of epidemiologic, animal, and mechanistic studies. It remains unclear which subgroups of users are at heightened risk. |
Author | Dart, Richard C. Schimmel, Jonathan |
Author_xml | – sequence: 1 givenname: Jonathan orcidid: 0000-0002-6383-8308 surname: Schimmel fullname: Schimmel, Jonathan email: Jonathan_Schimmel@med.brown.edu organization: Department of Emergency Medicine, Division of Medical Toxicology, Mount Sinai Hospital Icahn School of Medicine – sequence: 2 givenname: Richard C. surname: Dart fullname: Dart, Richard C. organization: Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31919755$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kMtOwzAQRS1URFvgB1igSGxgEfAjdmJWVBWPiiIkHmvLSSYlFXGCnRT173FJgR2L0Whm7twrnTEamNoAQkcEnxOM4wsXYSp4iIn0RSMaih00IiSWIZEcD9AI-3UohIiHaOzccjNKLvfQkBFJZMz5CF3dW93WVXD6ULZWL9ZGB88NZGXt9FkwL1dgg5lZdnZ9GUyCaV01Ft7AOH8InmBVwucB2i30u4PDbd9HrzfXL9O7cP54O5tO5mHGYt6GkLIcM5wwSnFEhMhiIMCFTJJcFwUQmWdxAgVL80xSnWSi4CSRLEooTwXknO2jk963sfVHB65Vy7qzxkcqygSVmFKBvYr2qszWzlkoVGPLStu1IlhtoKkemvLQ1Dc0JfzT8da6SyvIf19-KHkB6wXOn8wC7F_2P7ZfFgN3hA |
CitedBy_id | crossref_primary_10_1097_PAF_0000000000000691 crossref_primary_10_1016_j_transci_2024_103898 crossref_primary_10_1159_000539338 crossref_primary_10_1371_journal_pone_0288389 crossref_primary_10_14309_crj_0000000000000647 crossref_primary_10_1007_s40429_023_00465_8 crossref_primary_10_1016_j_ijbiomac_2024_133059 crossref_primary_10_3389_fphar_2024_1403140 crossref_primary_10_2903_j_efsa_2022_e200415 crossref_primary_10_1016_j_japh_2024_102138 crossref_primary_10_1016_j_drugalcdep_2022_109605 crossref_primary_10_3389_fpsyt_2020_594816 crossref_primary_10_1093_jpp_rgac062 crossref_primary_10_3389_fphar_2021_729220 crossref_primary_10_5497_wjp_v11_i3_16 crossref_primary_10_1055_a_1826_2766 crossref_primary_10_1053_j_gastro_2020_09_048 crossref_primary_10_3390_medicines7100062 crossref_primary_10_1080_02791072_2023_2242361 crossref_primary_10_1177_11795476221132824 crossref_primary_10_1016_j_psc_2022_04_002 crossref_primary_10_1016_j_emc_2021_04_013 crossref_primary_10_1016_j_jep_2023_117685 crossref_primary_10_1016_j_disamonth_2022_101442 crossref_primary_10_1016_j_biopha_2024_116134 crossref_primary_10_1111_add_15082 crossref_primary_10_1097_CLD_0000000000000220 crossref_primary_10_1213_ANE_0000000000006177 crossref_primary_10_1007_s40429_023_00477_4 crossref_primary_10_1124_dmd_122_001005 crossref_primary_10_3389_fpsyt_2021_640218 crossref_primary_10_1177_20503245211021193 crossref_primary_10_4254_wjh_v13_i9_1019 crossref_primary_10_1016_j_drugalcdep_2020_108426 crossref_primary_10_1016_j_fct_2022_113445 crossref_primary_10_3390_toxics10070398 crossref_primary_10_1080_17512433_2024_2305798 crossref_primary_10_1002_wfs2_1420 crossref_primary_10_1007_s00482_021_00588_9 crossref_primary_10_7759_cureus_14679 |
Cites_doi | 10.1016/S0618-8278(19)30242-7 10.1016/j.ajp.2019.05.016 10.1177/2324709619836138 10.1002/jms.1607 10.1002/ptr.5942 10.1016/S1386-6346(03)00232-8 10.1038/clpt.1981.154 10.1053/j.gastro.2011.07.051 10.1002/cpt.564 10.1016/j.jep.2012.03.009 10.1007/s00414-015-1279-y 10.3389/fphar.2019.00853 10.1002/hep.27612 10.1080/15563650.2019.1569236 10.1634/theoncologist.2017-0279 10.1007/s00210-018-01605-y 10.1016/j.cld.2007.06.003 10.1097/MJT.0000000000000631 10.1016/j.drugalcdep.2017.08.034 10.1053/jhep.2002.36088 10.1016/0895-4356(93)90101-6 10.3748/wjg.v19.i19.2864 10.3390/molecules18010666 10.1002/hep.23317 10.1016/S0016-5085(19)40307-7 10.1016/j.tox.2008.07.024 10.22159/ajpcr.2018.v11i3.22958 10.1007/s13181-011-0155-5 10.1002/hep.510260319 10.1016/j.jep.2013.02.008 10.3389/fnins.2015.00189 10.1016/j.ajem.2017.07.051 10.1097/MJT.0000000000000802 10.14309/00000434-201310001-00470 10.3390/ijms17020201 10.1016/j.jep.2017.12.017 10.1021/acs.jcim.6b00518 10.14740/gr990e 10.1517/17425255.2014.963555 10.3390/molecules15010432 10.14309/00000434-201710001-02150 10.1007/s11419-015-0305-6 10.1016/j.japh.2018.05.006 10.1002/hep.22442 10.1016/0895-4356(93)90102-7 10.1007/s000180300001 10.1080/02791072.2013.844532 10.1038/clpt.2011.58 10.14740/gr1204 10.1016/j.jep.2010.07.013 10.14309/01.ajg.0000599236.45119.13 10.1515/dmdi-2012-0039 10.3390/ijms17010014 10.1016/j.jhep.2011.02.007 10.14309/00000434-201110002-00753 10.1111/j.1365-2036.2007.03504.x 10.1080/20009666.2018.1468693 10.1080/02791072.2017.1371363 10.1021/jacs.6b00360 10.1002/hep.23577 |
ContentType | Journal Article |
Copyright | Springer Nature Switzerland AG 2020 Copyright Springer Nature B.V. Feb 2020 |
Copyright_xml | – notice: Springer Nature Switzerland AG 2020 – notice: Copyright Springer Nature B.V. Feb 2020 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 4T- 7QO 7RV 7TK 7U7 7U9 7X7 7XB 88E 8FD 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR C1K CCPQU FR3 FYUFA GHDGH H94 K9. KB0 M0S M1P NAPCQ P64 PQEST PQQKQ PQUKI PRINS |
DOI | 10.1007/s40265-019-01242-6 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Docstoc Biotechnology Research Abstracts Nursing & Allied Health Database Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central British Nursing Database ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Technology Research Database ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) Virology and AIDS Abstracts Toxicology Abstracts ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Docstoc ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | Technology Research Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1179-1950 |
EndPage | 283 |
ExternalDocumentID | 10_1007_s40265_019_01242_6 31919755 |
Genre | Journal Article Review |
GeographicLocations | Thailand United States--US Malaysia |
GeographicLocations_xml | – name: Thailand – name: Malaysia – name: United States--US |
GroupedDBID | --- -5G -BR -EM .55 .GJ .XZ 04C 0VX 29G 2JY 34G 36B 39C 3O- 3V. 4.4 406 53G 5GY 5RE 6I2 6PF 7RV 7X7 88E 8FI 8FJ 8R4 8R5 95. AAAUJ AABHQ AADNT AAFGU AAIAL AAIKX AAJKR AAKAS AAPBV AATNV AAWTL AAYFA AAYQN AAYTO ABCQX ABDZT ABFTV ABIPD ABJNI ABJOX ABKCH ABKMS ABKTR ABPLI ABPTK ABTKH ABTMW ABUWG ABUWZ ABWBT ABXPI ACBMV ACBRV ACBYP ACCUX ACGFS ACHVE ACIGE ACIWK ACMLO ACPRK ACTTH ACVWB ADBBV ADFZG ADHHG ADINQ ADKPE ADMDM ADQRH ADRFC ADURQ ADZCM ADZKW AEBTG AEFTE AEJHL AEJOU AEJRE AENEX AEOHA AEPKY AEPYU AEQTP AESKC AEYRQ AFALF AFFNX AFJLC AFKRA AFNRJ AFRAH AFWTZ AFZKB AGAYW AGDGC AGGBP AGQMX AHBYD AHIZS AHKMG AHMBA AHSBF AIAKS AILAN AJDOV ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AN0 ASKOH ASPBG AUKKA AVWKF AWSVR AXYYD AZFZN A~4 BENPR BGNMA BKEYQ BNQBC BPHCQ BVXVI CAG CCPQU COF CS3 DCUDU DPUIP DU5 EBLON EBS ECV EIHBH EJD ESX EX3 F5P FLLZZ FNLPD FSGXE FYUFA HF~ HMCUK IAO IEA IHR IMOTQ INH INR ITC IWAJR J-C JZLTJ L7B LLZTM M1P M4Y N4W NAPCQ NQJWS NU0 OAC OPC OVD P2P PCD PQQKQ PROAC PSQYO Q2X RKO ROL RSV RXW RZALA SISQX SJN SNPRN SOHCF SOJ SPKJE SRMVM SSLCW TEORI TSG U9L UG4 UKHRP UPIKM UPOSE UTJUX VDBLX VFIZW W48 WAF WOW WQ9 X7M Y6R YFH Z0Y Z5O Z7U Z7V Z7W Z7X Z81 Z82 Z83 Z84 Z87 ZA5 ZGI ZXP ~JE 0R~ AACDK AASML AAYZH ABAKF ABWHX ACAOD ACCOQ ACDTI ACZOJ AEBJR AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AIZAD ALIPV CGR CUY CVF ECM EIF FIGPU NPM SJYHP AAYXX CITATION 4T- 7QO 7TK 7U7 7U9 7XB 8FD 8FK C1K FR3 H94 K9. P64 PQEST PQUKI PRINS |
ID | FETCH-LOGICAL-c375t-eb3d030832204166c7e1e56988daffe19dc78ef3bdc92a8c6f518934825b6ed53 |
IEDL.DBID | 7X7 |
ISSN | 0012-6667 |
IngestDate | Thu Oct 10 22:02:20 EDT 2024 Thu Nov 21 21:24:19 EST 2024 Wed Oct 16 00:44:58 EDT 2024 Sat Dec 16 12:07:09 EST 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c375t-eb3d030832204166c7e1e56988daffe19dc78ef3bdc92a8c6f518934825b6ed53 |
ORCID | 0000-0002-6383-8308 |
PMID | 31919755 |
PQID | 2362902260 |
PQPubID | 34797 |
PageCount | 21 |
ParticipantIDs | proquest_journals_2362902260 crossref_primary_10_1007_s40265_019_01242_6 pubmed_primary_31919755 springer_journals_10_1007_s40265_019_01242_6 |
PublicationCentury | 2000 |
PublicationDate | 2020-02-01 |
PublicationDateYYYYMMDD | 2020-02-01 |
PublicationDate_xml | – month: 02 year: 2020 text: 2020-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: New Zealand – name: Auckland |
PublicationTitle | Drugs (New York, N.Y.) |
PublicationTitleAbbrev | Drugs |
PublicationTitleAlternate | Drugs |
PublicationYear | 2020 |
Publisher | Springer International Publishing Springer Nature B.V |
Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
References | Ya, Tangamornsuksan, Scholfield, Methaneethorn, Lohitnavy (CR74) 2019; 43 Arens, Gerona, Meier, Smollin (CR48) 2015; 53 Philipp, Wissenbach, Zoerntlein, Klein, Kanogsunthornrat, Maurer (CR77) 2009; 44 Manda, Avula, Dale, Ali, Khan, Walker (CR70) 2017; 31 Aithal, Watkins, Andrade, Larrey, Molokhia, Takikawa (CR54) 2011; 89 Hayashi (CR13) 2016; 17 Rochon, Protiva, Seeff, Fontana, Liangpunsakul, Watkins (CR21) 2008; 48 Paumgartner, Beuers (CR85) 2002; 36 Maria, Victorino (CR11) 1997; 26 Benichou, Danan, Flahault (CR16) 1993; 46 Sakaran, Othman, Jantan, Thent, Das (CR65) 2014; 3 Naranjo, Busto, Sellers, Sandor, Ruiz, Roberts (CR10) 1981; 30 Oliveira, Fraga, Carvalho (CR76) 2016; 34 Aldyab, Ells, Buib, Chapmanc, Lee (CR35) 2019; 12 Wang, Chai, Brewer, Chen (CR71) 2014; 10 Bøgevig, Breindal, Christensen, Nielsen, Hoegberg (CR43) 2019; 57 Haslan, Suhaimi, Das (CR68) 2018; 11 Danan, Teschke (CR18) 2019; 10 Kamal, Ghazali, Yahya (CR62) 2012; 1 Singh, Müller, Murugaiyah, Hamid, Vicknasingam, Avery (CR25) 2018; 214 Trakulsrichai, Tongpo, Sriapha, Wongvisawakorn, Rittilert, Kaojarern (CR5) 2013; 45 Mosedale, Watkins (CR9) 2017; 101 Rivera, Sharma, Shah (CR44) 2011; 106 Smith, Lawson (CR3) 2017; 180 Ricardo, Conte, Alkayali, Salem, Gastroenterology (CR42) 2019; 156 Davern, Chalasani, Fontana, Hayashi, Protiva, Kleiner (CR87) 2011; 141 Rusli, Amanah, Kaur, Adenan, Sulaiman, Wahab (CR81) 2019; 392 Riverso, Chang, Soldevila-Pico, Lai, Liu (CR29) 2018; 11 Harizal, Mansor, Hasnan, Tharakan, Abdullah (CR61) 2010; 131 Dorman, Wong, Khan (CR28) 2015; 61 Ahmad, Aziz (CR24) 2012; 141 Gijbels, Vinken (CR83) 2019 Osborne, Overstreet, Rockey, Schreiner (CR33) 2019; 7 CR8 Kesar, Michel, Weisberg (CR39) 2013; 108 CR7 Griffiths, Gandhi, Olin (CR30) 2018; 58 Zafarullah, Li, Sylvester, Ahmad (CR84) 2003; 60 Shah, Basit, Orlando (CR41) 2017; 112 Fernandes, Iqbal, Tighe, Ahmed (CR34) 2019; 7 Ali, Moklas, Taib (CR66) 2014; 5 Mousa, Sephien, Gutierrez, OʼLeary (CR31) 2018; 25 Saidin, Randall, Takayama (CR75) 2008; 1 Dalton, Fellows, Stableforth, Joseph, Thurairajah, Warshow (CR86) 2007; 26 Antony, Lee (CR32) 2019; 26 Kapp, Maurer, Auwärter, Winkelmann, Hermanns-Clausen (CR27) 2011; 7 Bernier, Allaire, Lelong-Boulouard, Rouillon, Boisselier (CR40) 2017; 31 Pronesti, Sial, Talwar, Aoun (CR45) 2019; 114 Shapiro, Lewis (CR20) 2007; 11 CR59 Danan, Benichou (CR14) 1993; 46 CR58 CR57 CR56 De Francesco, Lougheed, Mackenzie (CR50) 2019; 72 CR53 CR52 Griffin, Webb (CR6) 2018; 50 Cumpston, Carter, Wills (CR26) 2018; 36 CR51 Haron, Ismail (CR79) 2015; 7 Trakulsrichai, Sathirakul, Auparakkitanon, Krongvorakul, Sueajai, Noumjad (CR73) 2015; 9 Kaur, Siedlecki, Jafri (CR46) 2019; 34 Post, Spiller, Chounthirath, Smith (CR4) 2019; 57 Azizi, Ismail, Mordi, Ramanathan, Said, Mansor (CR80) 2010; 15 Danan, Teschke (CR17) 2016; 17 Tayabali, Bolzon, Foster, Patel, Kalim (CR36) 2018; 8 Takikawa, Takamori, Kumagi, Onji, Watanabe, Shibuya (CR12) 2003; 27 Teschke, Frenzel, Schulze, Eickhoff (CR22) 2013; 19 Fakurazi, Rahman, Hidayat, Ithnin, Moklas, Arulselvan (CR64) 2013; 18 Rockey, Seeff, Rochon, Freston, Chalasani, Bonacini (CR15) 2010; 51 Mackenzie, Thompson (CR49) 2018; 56 Drago, Lane, Kochav, Chabner (CR37) 2017; 22 Kupferschmidt (CR38) 2011; 49 Sabetghadam, Ramanathan, Sasidharan, Mansor (CR63) 2013; 146 García-Cortés, Stephens, Lucena, Fernández-Castañer, Andrade (CR19) 2011; 55 Suwanlert (CR23) 1975; 27 Azizi, Ismail, Mansor (CR78) 2013; 28 Warner, Kaufman, Grundmann (CR2) 2016; 130 Kruegel, Madalee, Kapoor, Váradi, Majumdar, Filizola (CR1) 2016; 138 Kotsampasakou, Ecker (CR82) 2017; 57 Macko, Weisbach, Douglas (CR60) 1972; 198 Ilmie, Jaafar, Mansor, Abdullah (CR67) 2015; 9 Desai, Ramachandra, Shah (CR47) 2019; 67 Lammert, Bjornsson, Niklasson, Chalasani (CR72) 2010; 51 Navarro, Odin, Ahmad, Hayashi, Fontana, Conjeevaram (CR55) 2019; 70 Guenther, Musick, Davis (CR69) 2019; 33 M Haron (1242_CR79) 2015; 7 K Ahmad (1242_CR24) 2012; 141 R Kaur (1242_CR46) 2019; 34 R Rivera (1242_CR44) 2011; 106 S Post (1242_CR4) 2019; 57 M Zafarullah (1242_CR84) 2003; 60 CT Fernandes (1242_CR34) 2019; 7 MU Ilmie (1242_CR67) 2015; 9 MA Shapiro (1242_CR20) 2007; 11 A Antony (1242_CR32) 2019; 26 HR Dalton (1242_CR86) 2007; 26 E Guenther (1242_CR69) 2019; 33 J Azizi (1242_CR80) 2010; 15 ML Warner (1242_CR2) 2016; 130 CL Griffiths (1242_CR30) 2018; 58 SRE Ali (1242_CR66) 2014; 5 S Fakurazi (1242_CR64) 2013; 18 Mina S. Mousa (1242_CR31) 2018; 25 GP Aithal (1242_CR54) 2011; 89 J Ricardo (1242_CR42) 2019; 156 TJ Davern (1242_CR87) 2011; 141 SR Shah (1242_CR41) 2017; 112 C Benichou (1242_CR16) 1993; 46 CS Osborne (1242_CR33) 2019; 7 G Danan (1242_CR17) 2016; 17 D Singh (1242_CR25) 2018; 214 NA Saidin (1242_CR75) 2008; 1 1242_CR52 YM Wang (1242_CR71) 2014; 10 JZ Drago (1242_CR37) 2017; 22 1242_CR53 C Mackenzie (1242_CR49) 2018; 56 1242_CR51 MS Kamal (1242_CR62) 2012; 1 S Trakulsrichai (1242_CR5) 2013; 45 E De Francesco (1242_CR50) 2019; 72 G Danan (1242_CR14) 1993; 46 1242_CR56 VA Maria (1242_CR11) 1997; 26 1242_CR57 1242_CR58 1242_CR59 J Rochon (1242_CR21) 2008; 48 KL Cumpston (1242_CR26) 2018; 36 AS Oliveira (1242_CR76) 2016; 34 S Bøgevig (1242_CR43) 2019; 57 E Macko (1242_CR60) 1972; 198 VJ Navarro (1242_CR55) 2019; 70 M Riverso (1242_CR29) 2018; 11 R Teschke (1242_CR22) 2013; 19 V Kesar (1242_CR39) 2013; 108 H Haslan (1242_CR68) 2018; 11 A Arens (1242_CR48) 2015; 53 J Azizi (1242_CR78) 2013; 28 K Tayabali (1242_CR36) 2018; 8 N Rusli (1242_CR81) 2019; 392 PH Hayashi (1242_CR13) 2016; 17 K Ya (1242_CR74) 2019; 43 AC Kruegel (1242_CR1) 2016; 138 C Lammert (1242_CR72) 2010; 51 DC Rockey (1242_CR15) 2010; 51 P Desai (1242_CR47) 2019; 67 AA Philipp (1242_CR77) 2009; 44 S Trakulsrichai (1242_CR73) 2015; 9 Eva Gijbels (1242_CR83) 2019 OH Griffin (1242_CR6) 2018; 50 M García-Cortés (1242_CR19) 2011; 55 M Aldyab (1242_CR35) 2019; 12 A Sabetghadam (1242_CR63) 2013; 146 R Sakaran (1242_CR65) 2014; 3 H Takikawa (1242_CR12) 2003; 27 G Paumgartner (1242_CR85) 2002; 36 H Kupferschmidt (1242_CR38) 2011; 49 M Bernier (1242_CR40) 2017; 31 FG Kapp (1242_CR27) 2011; 7 M Mosedale (1242_CR9) 2017; 101 KE Smith (1242_CR3) 2017; 180 1242_CR8 S Suwanlert (1242_CR23) 1975; 27 1242_CR7 G Danan (1242_CR18) 2019; 10 E Kotsampasakou (1242_CR82) 2017; 57 SN Harizal (1242_CR61) 2010; 131 C Dorman (1242_CR28) 2015; 61 V Pronesti (1242_CR45) 2019; 114 CA Naranjo (1242_CR10) 1981; 30 VK Manda (1242_CR70) 2017; 31 |
References_xml | – volume: 58 start-page: 561 issue: 5 year: 2018 end-page: 563 ident: CR30 article-title: Possible kratom-induced hepatomegaly: a case report publication-title: J Am Pharm Assoc contributor: fullname: Olin – volume: 11 start-page: 79 issue: 1 year: 2018 end-page: 82 ident: CR29 article-title: Histologic characterization of kratom use-associated liver Injury publication-title: Gastroenterol Res contributor: fullname: Liu – volume: 60 start-page: 6 issue: 1 year: 2003 end-page: 20 ident: CR84 article-title: Molecular mechanisms of -acetylcysteine actions publication-title: Cell Mol Life Sci contributor: fullname: Ahmad – volume: 72 start-page: 69 issue: 1 year: 2019 ident: CR50 article-title: Kratom-induced acute liver failure publication-title: Can J Hosp Pharm contributor: fullname: Mackenzie – volume: 146 start-page: 815 issue: 3 year: 2013 end-page: 823 ident: CR63 article-title: Subchronic exposure to mitragynine, the principal alkaloid of , in rats publication-title: J Ethnopharmacol contributor: fullname: Mansor – volume: 30 start-page: 239 issue: 2 year: 1981 end-page: 245 ident: CR10 article-title: A method for estimating the probability of adverse drug reactions publication-title: Clin Pharmacol Ther contributor: fullname: Roberts – volume: 43 start-page: 73 year: 2019 end-page: 82 ident: CR74 article-title: Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom ( ): a systematic review publication-title: Asian J Psychiatry contributor: fullname: Lohitnavy – volume: 51 start-page: 2117 issue: 6 year: 2010 end-page: 2126 ident: CR15 article-title: Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method publication-title: Hepatology contributor: fullname: Bonacini – volume: 25 start-page: e550 issue: 5 year: 2018 end-page: e551 ident: CR31 article-title: N-Acetylcysteine for Acute Hepatitis Induced by Kratom Herbal Tea publication-title: American Journal of Therapeutics contributor: fullname: OʼLeary – ident: CR51 – volume: 130 start-page: 127 issue: 1 year: 2016 end-page: 138 ident: CR2 article-title: The pharmacology and toxicology of kratom: from traditional herb to drug of abuse publication-title: Int J Legal Med contributor: fullname: Grundmann – volume: 8 start-page: 107 issue: 3 year: 2018 end-page: 110 ident: CR36 article-title: Kratom: a dangerous player in the opioid crisis publication-title: J Commun Hosp Internal Med Perspect contributor: fullname: Kalim – volume: 17 start-page: 14 issue: 1 year: 2016 end-page: 46 ident: CR17 article-title: RUCAM in drug and herb induced liver injury: the update publication-title: Int J Mol Sci. contributor: fullname: Teschke – volume: 61 start-page: 1086 issue: 3 year: 2015 end-page: 1087 ident: CR28 article-title: Cholestatic hepatitis from prolonged kratom use: a case report publication-title: Hepatology contributor: fullname: Khan – volume: 70 start-page: 138A issue: 1 year: 2019 ident: CR55 article-title: Increasing episodes of hepatotoxicity in the drug induced liver injury network associated with kratom, a botanical product with opioid-like activity publication-title: Hepatology contributor: fullname: Conjeevaram – volume: 11 start-page: 477 issue: 3 year: 2007 end-page: 505 ident: CR20 article-title: Causality assessment of drug-induced hepatotoxicity: promises and pitfalls publication-title: Clin Liver Dis. contributor: fullname: Lewis – volume: 53 start-page: 661 issue: 7 year: 2015 ident: CR48 article-title: Acute cholecystitis associated with Kratom abuse publication-title: Clin Toxicol contributor: fullname: Smollin – ident: CR8 – ident: CR58 – volume: 27 start-page: 21 issue: 3 year: 1975 end-page: 27 ident: CR23 article-title: A study of kratom eaters in Thailand publication-title: Bull Narc contributor: fullname: Suwanlert – volume: 26 start-page: 664 issue: 3 year: 1997 end-page: 669 ident: CR11 article-title: Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis publication-title: Hepatology contributor: fullname: Victorino – volume: 180 start-page: 340 year: 2017 end-page: 348 ident: CR3 article-title: Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program publication-title: Drug Alcohol Depend contributor: fullname: Lawson – volume: 114 start-page: S1344 year: 2019 ident: CR45 article-title: Cholestatic liver injury caused by kratom ingestion: 2426 publication-title: Am J Gastroenterol contributor: fullname: Aoun – volume: 106 start-page: S284 year: 2011 ident: CR44 article-title: Liver toxicity following abuse of kratom ( ): 753 publication-title: Am J Gastroenterol contributor: fullname: Shah – volume: 7 start-page: 227 issue: 3 year: 2011 end-page: 231 ident: CR27 article-title: Intrahepatic cholestasis following abuse of powdered kratom ( ) publication-title: J Med Toxicol contributor: fullname: Hermanns-Clausen – volume: 18 start-page: 666 issue: 1 year: 2013 end-page: 681 ident: CR64 article-title: The combination of mitragynine and morphine prevents the development of morphine tolerance in mice publication-title: Molecules contributor: fullname: Arulselvan – start-page: 1 year: 2019 end-page: 14 ident: CR83 article-title: Mechanisms of Drug-Induced Cholestasis publication-title: Methods in Molecular Biology contributor: fullname: Vinken – volume: 26 start-page: 1429 issue: 10 year: 2007 end-page: 1435 ident: CR86 article-title: The role of hepatitis E virus testing in drug-induced liver injury publication-title: Aliment Pharmacol Ther contributor: fullname: Warshow – volume: 141 start-page: 446 issue: 1 year: 2012 end-page: 450 ident: CR24 article-title: Mitragyna speciosa use in the northern states of Malaysia: a cross-sectional study publication-title: J Ethnopharmacol contributor: fullname: Aziz – volume: 108 start-page: S106 year: 2013 end-page: S161 ident: CR39 article-title: Mitragyna Speciosa (Kratom)-induced cholestatic hepatitis in abstracts Submitted for the 78th Annual Scientific Meeting of the American College of Gastroenterology publication-title: Am J Gastroenterol. contributor: fullname: Weisberg – volume: 51 start-page: 615 issue: 2 year: 2010 end-page: 620 ident: CR72 article-title: Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events publication-title: Hepatology contributor: fullname: Chalasani – ident: CR57 – volume: 31 start-page: 1935 issue: 12 year: 2017 end-page: 1945 ident: CR70 article-title: PXR mediated induction of CYP3A4, CYP1A2, and P-gp by and its alkaloids publication-title: Phytother Res. contributor: fullname: Walker – volume: 55 start-page: 683 issue: 3 year: 2011 end-page: 691 ident: CR19 article-title: Causality assessment methods in drug induced liver injury: strengths and weaknesses publication-title: J Hepatol contributor: fullname: Andrade – volume: 214 start-page: 197 year: 2018 end-page: 206 ident: CR25 article-title: Evaluating the hematological and clinical-chemistry parameters of kratom ( ) users in Malaysia publication-title: J Ethnopharmacol contributor: fullname: Avery – volume: 141 start-page: 1665 issue: 5 year: 2011 end-page: 72.e1 ident: CR87 article-title: Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury publication-title: Gastroenterology contributor: fullname: Kleiner – volume: 138 start-page: 6754 issue: 21 year: 2016 end-page: 6764 ident: CR1 article-title: Synthetic and receptor signaling explorations of the mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators publication-title: J Am Chem Soc contributor: fullname: Filizola – volume: 46 start-page: 1331 issue: 11 year: 1993 end-page: 1336 ident: CR16 article-title: Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge publication-title: J Clin Epidemiol. contributor: fullname: Flahault – volume: 15 start-page: 432 issue: 1 year: 2010 end-page: 441 ident: CR80 article-title: In vitro and in vivo effects of three different Mitragyna speciosa korth leaf extracts on phase II drug metabolizing enzymes—glutathione transferases (GSTs) publication-title: Molecules contributor: fullname: Mansor – volume: 34 start-page: 213 issue: 2 year: 2016 end-page: 226 ident: CR76 article-title: Chemical characterization and in vitro cyto-and genotoxicity of ‘legal high’ products containing Kratom ( ) publication-title: Forensic Toxicol contributor: fullname: Carvalho – volume: 198 start-page: 145 issue: 1 year: 1972 end-page: 161 ident: CR60 article-title: Some observations on the pharmacology of mitragynine publication-title: Arch Int Pharmacodyn Ther contributor: fullname: Douglas – volume: 22 start-page: 1010 issue: 8 year: 2017 end-page: 1011 ident: CR37 article-title: The harm in kratom publication-title: Oncologist. contributor: fullname: Chabner – volume: 28 start-page: 95 issue: 2 year: 2013 end-page: 105 ident: CR78 article-title: Korth leaves extracts induced the CYP450 catalyzed aminopyrine- -demethylase (APND) and UDP-glucuronosyl transferase (UGT) activities in male Sprague-Dawley rat livers publication-title: Drug Metab Drug Interact contributor: fullname: Mansor – volume: 57 start-page: 527 issue: 6 year: 2019 ident: CR43 article-title: Severe liver injury caused by recommended doses of the food supplement kratom publication-title: Clin Toxicol contributor: fullname: Hoegberg – volume: 7 start-page: 1 year: 2019 end-page: 5 ident: CR33 article-title: Drug-induced liver injury caused by kratom use as an alternative pain treatment amid an ongoing opioid epidemic publication-title: J Investig Med High Impact Case Rep. contributor: fullname: Schreiner – volume: 50 start-page: 114 issue: 2 year: 2018 end-page: 120 ident: CR6 article-title: The scheduling of kratom and selective use of data publication-title: J Psychoact Drugs contributor: fullname: Webb – volume: 48 start-page: 1175 issue: 4 year: 2008 end-page: 1183 ident: CR21 article-title: Reliability of the Roussel Uclaf causality assessment method for assessing causality in drug-induced liver injury publication-title: Hepatology contributor: fullname: Watkins – volume: 26 start-page: e546 issue: 4 year: 2019 end-page: e547 ident: CR32 article-title: Herb-induced liver injury with cholestasis and renal injury secondary to short-term use of kratom ( ) publication-title: Am J Ther contributor: fullname: Lee – volume: 34 start-page: S425 issue: 2 year: 2019 end-page: S426 ident: CR46 article-title: A case of kratom induced cholestasis publication-title: J Gen Intern Med. contributor: fullname: Jafri – volume: 3 start-page: 2 year: 2014 ident: CR65 article-title: Effect of subacute dose of Korth crude extract in female sprague dawley rats publication-title: J Med Bioeng. contributor: fullname: Das – ident: CR53 – volume: 9 start-page: 2421 year: 2015 end-page: 2429 ident: CR73 article-title: Pharmacokinetics of mitragynine in man publication-title: Drug Des Dev Ther contributor: fullname: Noumjad – volume: 10 start-page: 853 year: 2019 ident: CR18 article-title: Roussel uclaf causality assessment method for drug-induced liver injury: present and future publication-title: Front Pharmacol contributor: fullname: Teschke – volume: 57 start-page: 847 issue: 10 year: 2019 end-page: 854 ident: CR4 article-title: Kratom exposures reported to United States poison control centers: 2011–2017 publication-title: Clin Toxicol contributor: fullname: Smith – volume: 46 start-page: 1323 issue: 11 year: 1993 end-page: 1330 ident: CR14 article-title: Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries publication-title: J Clin Epidemiol. contributor: fullname: Benichou – volume: 31 start-page: 19 year: 2017 end-page: 21 ident: CR40 article-title: Inserm. Kratom (Mitragyna speciosa) “phyto-toxicomania": about a case of acute hepatitis publication-title: Fundam Clin Pharmacol. contributor: fullname: Boisselier – volume: 7 start-page: 4 year: 2015 ident: CR79 article-title: Effects of mitragynine and 7-hydroxymitragynine (the alkaloids of Mitragyna speciosa Korth) on 4-methylumbelliferone glucuronidation in rat and human liver microsomes and recombinant human uridine 5’-diphospho-glucuronosyltransferase isoforms publication-title: Pharmacogn Res. contributor: fullname: Ismail – volume: 9 start-page: 189 year: 2015 ident: CR67 article-title: Subchronic toxicity study of standardized methanolic extract of Korth in Sprague-Dawley Rats publication-title: Front Neurosci contributor: fullname: Abdullah – volume: 45 start-page: 404 issue: 5 year: 2013 end-page: 408 ident: CR5 article-title: Kratom abuse in ramathibodi Poison Center, Thailand: a five-year experience publication-title: J Psychoact Drugs contributor: fullname: Kaojarern – volume: 19 start-page: 2864 issue: 19 year: 2013 end-page: 2882 ident: CR22 article-title: Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods publication-title: World J Gastroenterol contributor: fullname: Eickhoff – volume: 33 start-page: 765 issue: Suppl 1 year: 2019 end-page: 768 ident: CR69 article-title: Faseb. Reversal of hepatomegaly following cessation of Kratom Consumption in C57BL/6 male and female mice publication-title: FASEB J. contributor: fullname: Davis – ident: CR56 – volume: 11 start-page: 43 issue: 3 year: 2018 end-page: 46 ident: CR68 article-title: Mitragyna speciosa-induced hepatotoxicity-treated effectively by piper betle: scope as a future antidote publication-title: Asian J Pharm Clin Res. contributor: fullname: Das – volume: 36 start-page: 525 issue: 3 year: 2002 end-page: 531 ident: CR85 article-title: Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited publication-title: Hepatology contributor: fullname: Beuers – volume: 49 start-page: 532 issue: 6 year: 2011 ident: CR38 article-title: Toxic hepatitis after Kratom ( sp.) consumption publication-title: Clin Toxicol. contributor: fullname: Kupferschmidt – volume: 112 start-page: S1190 year: 2017 ident: CR41 article-title: Kratom-induced severe intrahepatic cholestasis: a case report publication-title: Am J Gastroenterol. contributor: fullname: Orlando – volume: 10 start-page: 1521 issue: 11 year: 2014 end-page: 1532 ident: CR71 article-title: Pregnane X receptor and drug-induced liver injury publication-title: Expert Opin Drug Metab Toxicol. contributor: fullname: Chen – volume: 89 start-page: 806 issue: 6 year: 2011 end-page: 815 ident: CR54 article-title: Case definition and phenotype standardization in drug-induced liver injury publication-title: Clin Pharmacol Ther contributor: fullname: Takikawa – volume: 57 start-page: 608 issue: 3 year: 2017 end-page: 615 ident: CR82 article-title: Predicting drug-induced cholestasis with the help of hepatic transporters-an in silico modeling approach publication-title: J Chem Inf Model contributor: fullname: Ecker – volume: 67 start-page: 606 issue: 2 year: 2019 ident: CR47 article-title: Kratom induced hepatotoxicity and the role of N-acetyl cysteine. Abstract from conference: Southern Regional Meeting 2019 publication-title: J Investig Med High Impact Case Rep. contributor: fullname: Shah – volume: 56 start-page: 947 issue: 19 year: 2018 ident: CR49 article-title: Salmonella contaminated Kratom ingestion associated with fulminant hepatic failure requiring liver transplantation publication-title: Clin Toxicol contributor: fullname: Thompson – volume: 1 start-page: 2 year: 2012 ident: CR62 article-title: Acute toxicity study of standardized korth aqueous extract in Sprague dawley rats publication-title: J Plant Stud. contributor: fullname: Yahya – volume: 36 start-page: 166 issue: 1 year: 2018 end-page: 168 ident: CR26 article-title: Clinical outcomes after Kratom exposures: a poison center case series publication-title: Am J Emerg Med contributor: fullname: Wills – volume: 12 start-page: 211 issue: 4 year: 2019 end-page: 215 ident: CR35 article-title: Kratom-induced cholestatic liver injury mimicking anti-mitochondrial antibody-negative primary biliary cholangitis: a case report and review of literature publication-title: Gastroenterol Res. contributor: fullname: Lee – volume: 101 start-page: 469 issue: 4 year: 2017 end-page: 480 ident: CR9 article-title: Drug-induced liver injury: advances in mechanistic understanding that will inform risk management publication-title: Clin Pharmacol Ther contributor: fullname: Watkins – ident: CR52 – volume: 1 start-page: 19 issue: 253 year: 2008 end-page: 20 ident: CR75 article-title: Malaysian Kratom, a phyto-pharmaceutical of abuse: studies on the mechanism of its cytotoxicity publication-title: Toxicology contributor: fullname: Takayama – volume: 17 start-page: 201 issue: 2 year: 2016 ident: CR13 article-title: Drug-induced liver injury network causality assessment: criteria and experience in the United States publication-title: Int J Mol Sci contributor: fullname: Hayashi – volume: 5 start-page: 32 issue: 5 year: 2014 ident: CR66 article-title: DREAM and C-fos proteins expression after treatment with malaysian publication-title: Res J Pharm Biol Chem Sci contributor: fullname: Taib – volume: 156 start-page: S1316 issue: 6 year: 2019 ident: CR42 article-title: Mo1466-Kratom induced cholestatic hepatitis publication-title: Gastroenterology contributor: fullname: Gastroenterology – ident: CR7 – ident: CR59 – volume: 27 start-page: 192 issue: 3 year: 2003 end-page: 195 ident: CR12 article-title: Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting publication-title: Hepatol Res contributor: fullname: Shibuya – volume: 44 start-page: 1249 issue: 8 year: 2009 end-page: 1261 ident: CR77 article-title: Studies on the metabolism of mitragynine, the main alkaloid of the herbal drug Kratom, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry publication-title: J Mass Spectrom contributor: fullname: Maurer – volume: 131 start-page: 404 issue: 2 year: 2010 end-page: 409 ident: CR61 article-title: Acute toxicity study of the standardized methanolic extract of Korth in rodent publication-title: J Ethnopharmacol contributor: fullname: Abdullah – volume: 392 start-page: 481 issue: 4 year: 2019 end-page: 496 ident: CR81 article-title: The inhibitory effects of mitragynine on P-glycoprotein in vitro publication-title: Naunyn Schmiedeberg's Arch Pharmacol. contributor: fullname: Wahab – volume: 7 start-page: 2324709619836138 year: 2019 ident: CR34 article-title: Kratom-induced cholestatic liver injury and its conservative management publication-title: J Investig Med High Impact Case Rep. contributor: fullname: Ahmed – volume: 70 start-page: 138A issue: 1 year: 2019 ident: 1242_CR55 publication-title: Hepatology doi: 10.1016/S0618-8278(19)30242-7 contributor: fullname: VJ Navarro – volume: 43 start-page: 73 year: 2019 ident: 1242_CR74 publication-title: Asian J Psychiatry doi: 10.1016/j.ajp.2019.05.016 contributor: fullname: K Ya – volume: 7 start-page: 232470961983613 year: 2019 ident: 1242_CR34 publication-title: J Investig Med High Impact Case Rep. doi: 10.1177/2324709619836138 contributor: fullname: CT Fernandes – volume: 44 start-page: 1249 issue: 8 year: 2009 ident: 1242_CR77 publication-title: J Mass Spectrom doi: 10.1002/jms.1607 contributor: fullname: AA Philipp – volume: 31 start-page: 1935 issue: 12 year: 2017 ident: 1242_CR70 publication-title: Phytother Res. doi: 10.1002/ptr.5942 contributor: fullname: VK Manda – volume: 27 start-page: 192 issue: 3 year: 2003 ident: 1242_CR12 publication-title: Hepatol Res doi: 10.1016/S1386-6346(03)00232-8 contributor: fullname: H Takikawa – volume: 30 start-page: 239 issue: 2 year: 1981 ident: 1242_CR10 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.1981.154 contributor: fullname: CA Naranjo – volume: 67 start-page: 606 issue: 2 year: 2019 ident: 1242_CR47 publication-title: J Investig Med High Impact Case Rep. contributor: fullname: P Desai – volume: 141 start-page: 1665 issue: 5 year: 2011 ident: 1242_CR87 publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.07.051 contributor: fullname: TJ Davern – volume: 27 start-page: 21 issue: 3 year: 1975 ident: 1242_CR23 publication-title: Bull Narc contributor: fullname: S Suwanlert – volume: 33 start-page: 765 issue: Suppl 1 year: 2019 ident: 1242_CR69 publication-title: FASEB J. contributor: fullname: E Guenther – volume: 7 start-page: 1 year: 2019 ident: 1242_CR33 publication-title: J Investig Med High Impact Case Rep. contributor: fullname: CS Osborne – ident: 1242_CR53 – volume: 101 start-page: 469 issue: 4 year: 2017 ident: 1242_CR9 publication-title: Clin Pharmacol Ther doi: 10.1002/cpt.564 contributor: fullname: M Mosedale – volume: 141 start-page: 446 issue: 1 year: 2012 ident: 1242_CR24 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2012.03.009 contributor: fullname: K Ahmad – volume: 130 start-page: 127 issue: 1 year: 2016 ident: 1242_CR2 publication-title: Int J Legal Med doi: 10.1007/s00414-015-1279-y contributor: fullname: ML Warner – volume: 10 start-page: 853 year: 2019 ident: 1242_CR18 publication-title: Front Pharmacol doi: 10.3389/fphar.2019.00853 contributor: fullname: G Danan – ident: 1242_CR57 – volume: 49 start-page: 532 issue: 6 year: 2011 ident: 1242_CR38 publication-title: Clin Toxicol. contributor: fullname: H Kupferschmidt – volume: 61 start-page: 1086 issue: 3 year: 2015 ident: 1242_CR28 publication-title: Hepatology doi: 10.1002/hep.27612 contributor: fullname: C Dorman – volume: 72 start-page: 69 issue: 1 year: 2019 ident: 1242_CR50 publication-title: Can J Hosp Pharm contributor: fullname: E De Francesco – volume: 57 start-page: 847 issue: 10 year: 2019 ident: 1242_CR4 publication-title: Clin Toxicol doi: 10.1080/15563650.2019.1569236 contributor: fullname: S Post – volume: 1 start-page: 2 year: 2012 ident: 1242_CR62 publication-title: J Plant Stud. contributor: fullname: MS Kamal – volume: 22 start-page: 1010 issue: 8 year: 2017 ident: 1242_CR37 publication-title: Oncologist. doi: 10.1634/theoncologist.2017-0279 contributor: fullname: JZ Drago – volume: 392 start-page: 481 issue: 4 year: 2019 ident: 1242_CR81 publication-title: Naunyn Schmiedeberg's Arch Pharmacol. doi: 10.1007/s00210-018-01605-y contributor: fullname: N Rusli – volume: 11 start-page: 477 issue: 3 year: 2007 ident: 1242_CR20 publication-title: Clin Liver Dis. doi: 10.1016/j.cld.2007.06.003 contributor: fullname: MA Shapiro – volume: 5 start-page: 32 issue: 5 year: 2014 ident: 1242_CR66 publication-title: Res J Pharm Biol Chem Sci contributor: fullname: SRE Ali – volume: 57 start-page: 527 issue: 6 year: 2019 ident: 1242_CR43 publication-title: Clin Toxicol contributor: fullname: S Bøgevig – volume: 25 start-page: e550 issue: 5 year: 2018 ident: 1242_CR31 publication-title: American Journal of Therapeutics doi: 10.1097/MJT.0000000000000631 contributor: fullname: Mina S. Mousa – volume: 180 start-page: 340 year: 2017 ident: 1242_CR3 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2017.08.034 contributor: fullname: KE Smith – volume: 36 start-page: 525 issue: 3 year: 2002 ident: 1242_CR85 publication-title: Hepatology doi: 10.1053/jhep.2002.36088 contributor: fullname: G Paumgartner – volume: 3 start-page: 2 year: 2014 ident: 1242_CR65 publication-title: J Med Bioeng. contributor: fullname: R Sakaran – volume: 46 start-page: 1323 issue: 11 year: 1993 ident: 1242_CR14 publication-title: J Clin Epidemiol. doi: 10.1016/0895-4356(93)90101-6 contributor: fullname: G Danan – volume: 19 start-page: 2864 issue: 19 year: 2013 ident: 1242_CR22 publication-title: World J Gastroenterol doi: 10.3748/wjg.v19.i19.2864 contributor: fullname: R Teschke – volume: 34 start-page: S425 issue: 2 year: 2019 ident: 1242_CR46 publication-title: J Gen Intern Med. contributor: fullname: R Kaur – volume: 18 start-page: 666 issue: 1 year: 2013 ident: 1242_CR64 publication-title: Molecules doi: 10.3390/molecules18010666 contributor: fullname: S Fakurazi – volume: 51 start-page: 615 issue: 2 year: 2010 ident: 1242_CR72 publication-title: Hepatology doi: 10.1002/hep.23317 contributor: fullname: C Lammert – volume: 156 start-page: S1316 issue: 6 year: 2019 ident: 1242_CR42 publication-title: Gastroenterology doi: 10.1016/S0016-5085(19)40307-7 contributor: fullname: J Ricardo – ident: 1242_CR58 – volume: 1 start-page: 19 issue: 253 year: 2008 ident: 1242_CR75 publication-title: Toxicology doi: 10.1016/j.tox.2008.07.024 contributor: fullname: NA Saidin – volume: 56 start-page: 947 issue: 19 year: 2018 ident: 1242_CR49 publication-title: Clin Toxicol contributor: fullname: C Mackenzie – volume: 11 start-page: 43 issue: 3 year: 2018 ident: 1242_CR68 publication-title: Asian J Pharm Clin Res. doi: 10.22159/ajpcr.2018.v11i3.22958 contributor: fullname: H Haslan – volume: 31 start-page: 19 year: 2017 ident: 1242_CR40 publication-title: Fundam Clin Pharmacol. contributor: fullname: M Bernier – volume: 7 start-page: 227 issue: 3 year: 2011 ident: 1242_CR27 publication-title: J Med Toxicol doi: 10.1007/s13181-011-0155-5 contributor: fullname: FG Kapp – volume: 26 start-page: 664 issue: 3 year: 1997 ident: 1242_CR11 publication-title: Hepatology doi: 10.1002/hep.510260319 contributor: fullname: VA Maria – volume: 146 start-page: 815 issue: 3 year: 2013 ident: 1242_CR63 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2013.02.008 contributor: fullname: A Sabetghadam – volume: 9 start-page: 189 year: 2015 ident: 1242_CR67 publication-title: Front Neurosci doi: 10.3389/fnins.2015.00189 contributor: fullname: MU Ilmie – ident: 1242_CR7 – volume: 36 start-page: 166 issue: 1 year: 2018 ident: 1242_CR26 publication-title: Am J Emerg Med doi: 10.1016/j.ajem.2017.07.051 contributor: fullname: KL Cumpston – ident: 1242_CR51 – volume: 53 start-page: 661 issue: 7 year: 2015 ident: 1242_CR48 publication-title: Clin Toxicol contributor: fullname: A Arens – volume: 26 start-page: e546 issue: 4 year: 2019 ident: 1242_CR32 publication-title: Am J Ther doi: 10.1097/MJT.0000000000000802 contributor: fullname: A Antony – volume: 108 start-page: S106 year: 2013 ident: 1242_CR39 publication-title: Am J Gastroenterol. doi: 10.14309/00000434-201310001-00470 contributor: fullname: V Kesar – volume: 17 start-page: 201 issue: 2 year: 2016 ident: 1242_CR13 publication-title: Int J Mol Sci doi: 10.3390/ijms17020201 contributor: fullname: PH Hayashi – volume: 214 start-page: 197 year: 2018 ident: 1242_CR25 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2017.12.017 contributor: fullname: D Singh – volume: 7 start-page: 4 year: 2015 ident: 1242_CR79 publication-title: Pharmacogn Res. contributor: fullname: M Haron – volume: 57 start-page: 608 issue: 3 year: 2017 ident: 1242_CR82 publication-title: J Chem Inf Model doi: 10.1021/acs.jcim.6b00518 contributor: fullname: E Kotsampasakou – volume: 11 start-page: 79 issue: 1 year: 2018 ident: 1242_CR29 publication-title: Gastroenterol Res doi: 10.14740/gr990e contributor: fullname: M Riverso – start-page: 1 volume-title: Methods in Molecular Biology year: 2019 ident: 1242_CR83 contributor: fullname: Eva Gijbels – volume: 10 start-page: 1521 issue: 11 year: 2014 ident: 1242_CR71 publication-title: Expert Opin Drug Metab Toxicol. doi: 10.1517/17425255.2014.963555 contributor: fullname: YM Wang – ident: 1242_CR59 – volume: 15 start-page: 432 issue: 1 year: 2010 ident: 1242_CR80 publication-title: Molecules doi: 10.3390/molecules15010432 contributor: fullname: J Azizi – volume: 112 start-page: S1190 year: 2017 ident: 1242_CR41 publication-title: Am J Gastroenterol. doi: 10.14309/00000434-201710001-02150 contributor: fullname: SR Shah – volume: 34 start-page: 213 issue: 2 year: 2016 ident: 1242_CR76 publication-title: Forensic Toxicol doi: 10.1007/s11419-015-0305-6 contributor: fullname: AS Oliveira – volume: 58 start-page: 561 issue: 5 year: 2018 ident: 1242_CR30 publication-title: J Am Pharm Assoc doi: 10.1016/j.japh.2018.05.006 contributor: fullname: CL Griffiths – volume: 48 start-page: 1175 issue: 4 year: 2008 ident: 1242_CR21 publication-title: Hepatology doi: 10.1002/hep.22442 contributor: fullname: J Rochon – ident: 1242_CR8 – volume: 46 start-page: 1331 issue: 11 year: 1993 ident: 1242_CR16 publication-title: J Clin Epidemiol. doi: 10.1016/0895-4356(93)90102-7 contributor: fullname: C Benichou – volume: 60 start-page: 6 issue: 1 year: 2003 ident: 1242_CR84 publication-title: Cell Mol Life Sci doi: 10.1007/s000180300001 contributor: fullname: M Zafarullah – volume: 45 start-page: 404 issue: 5 year: 2013 ident: 1242_CR5 publication-title: J Psychoact Drugs doi: 10.1080/02791072.2013.844532 contributor: fullname: S Trakulsrichai – volume: 89 start-page: 806 issue: 6 year: 2011 ident: 1242_CR54 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2011.58 contributor: fullname: GP Aithal – volume: 12 start-page: 211 issue: 4 year: 2019 ident: 1242_CR35 publication-title: Gastroenterol Res. doi: 10.14740/gr1204 contributor: fullname: M Aldyab – volume: 131 start-page: 404 issue: 2 year: 2010 ident: 1242_CR61 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2010.07.013 contributor: fullname: SN Harizal – volume: 114 start-page: S1344 year: 2019 ident: 1242_CR45 publication-title: Am J Gastroenterol doi: 10.14309/01.ajg.0000599236.45119.13 contributor: fullname: V Pronesti – ident: 1242_CR52 – volume: 198 start-page: 145 issue: 1 year: 1972 ident: 1242_CR60 publication-title: Arch Int Pharmacodyn Ther contributor: fullname: E Macko – volume: 28 start-page: 95 issue: 2 year: 2013 ident: 1242_CR78 publication-title: Drug Metab Drug Interact doi: 10.1515/dmdi-2012-0039 contributor: fullname: J Azizi – volume: 17 start-page: 14 issue: 1 year: 2016 ident: 1242_CR17 publication-title: Int J Mol Sci. doi: 10.3390/ijms17010014 contributor: fullname: G Danan – volume: 55 start-page: 683 issue: 3 year: 2011 ident: 1242_CR19 publication-title: J Hepatol doi: 10.1016/j.jhep.2011.02.007 contributor: fullname: M García-Cortés – volume: 106 start-page: S284 year: 2011 ident: 1242_CR44 publication-title: Am J Gastroenterol doi: 10.14309/00000434-201110002-00753 contributor: fullname: R Rivera – volume: 9 start-page: 2421 year: 2015 ident: 1242_CR73 publication-title: Drug Des Dev Ther contributor: fullname: S Trakulsrichai – volume: 26 start-page: 1429 issue: 10 year: 2007 ident: 1242_CR86 publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2007.03504.x contributor: fullname: HR Dalton – volume: 8 start-page: 107 issue: 3 year: 2018 ident: 1242_CR36 publication-title: J Commun Hosp Internal Med Perspect doi: 10.1080/20009666.2018.1468693 contributor: fullname: K Tayabali – volume: 50 start-page: 114 issue: 2 year: 2018 ident: 1242_CR6 publication-title: J Psychoact Drugs doi: 10.1080/02791072.2017.1371363 contributor: fullname: OH Griffin – ident: 1242_CR56 – volume: 138 start-page: 6754 issue: 21 year: 2016 ident: 1242_CR1 publication-title: J Am Chem Soc doi: 10.1021/jacs.6b00360 contributor: fullname: AC Kruegel – volume: 51 start-page: 2117 issue: 6 year: 2010 ident: 1242_CR15 publication-title: Hepatology doi: 10.1002/hep.23577 contributor: fullname: DC Rockey |
SSID | ssj0012959 |
Score | 2.535327 |
SecondaryResourceType | review_article |
Snippet | Kratom (
Mitragyna speciosa
) leaves contain the mu opioid partial agonists mitragynine and 7-hydroxymitragynine. The US Drug Enforcement Agency considers it a... Kratom (Mitragyna speciosa) leaves contain the mu opioid partial agonists mitragynine and 7-hydroxymitragynine. The US Drug Enforcement Agency considers it a... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 263 |
SubjectTerms | Analgesics, Opioid - adverse effects Analgesics, Opioid - chemistry Analgesics, Opioid - isolation & purification Bile Biopsy Cardiovascular disease Case reports Causality Chemical and Drug Induced Liver Injury Cholestasis - chemically induced Epidemiology Gallbladder diseases Hepatitis Hepatotoxicity Humans Injuries Internal Medicine International organizations Jaundice Latency Liver Medicine Medicine & Public Health Mitragyna - chemistry Narcotics Opioid receptors (type mu) Pharmacology/Toxicology Pharmacotherapy Plant Leaves - chemistry Review Article Reviewing Secologanin Tryptamine Alkaloids - adverse effects Secologanin Tryptamine Alkaloids - chemistry Secologanin Tryptamine Alkaloids - isolation & purification Signs and symptoms Subgroups |
Title | Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review |
URI | https://link.springer.com/article/10.1007/s40265-019-01242-6 https://www.ncbi.nlm.nih.gov/pubmed/31919755 https://www.proquest.com/docview/2362902260 |
Volume | 80 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB60XryIb6tV9iCi2MVumt0kXrQVi89SxEJvYV_xAaa1rYf-e2eTtEVETzklC99m55tvZnYG4FAZqQ1SK7WJdKEbz9JQcJ9aT2rFrdKBcnHIx7a46fp3Pd4rAm6joqxyahMzQ2362sXIzzy0tBESjqhdDD6pmxrlsqvFCI1FWGIeUjn-z0FvJriQynju_jKPopseFJdmsqtzqJuEK1tz1UJIU1T8JKZf3uavTGlGQK1VWCk8R9LIt3oNFmy6DkedvPX0pEqe5zepRlVyRDrzptSTDbi8d_n0D3L8-DYeypdJKkk2er4_kifkwRVnkNv0HQE-Jw3ijMTQvua17SRPH2xCt3X9fHVDi-kJVNcDPqaoko1rRoMntoZel9CBZZaLKAyNTBLLIqOD0CZ1ZXTkyVCLhDN0XnyUjEpYw-tbUEr7qd0B4kQG58Ki9kh8w4JQ-Ux6qD-NZMoXrAynU-jiQd4kI561Q86AjhHoOAM6FmWoTNGNiwMziufbW4btHPHZp9BKsCjgvAzV6RbMX_x7nd3_19mDZc9p56wCuwKl8fDL7qODMVYH2V90AEuNVrPZxmfzut15-gassszC |
link.rule.ids | 314,780,784,12056,21388,27924,27925,31719,33744,43310,43805,73745,74302 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwEB1BOcAFsVMo4ANCIGqB09hJuLCpqEBbVahI3CJvYZFIoS2H_j3jJG2FEHxAbOk5nnlvZjwDsK-M1AZdK7WJdKEbz9JQcJ9aT2rFrdKBcnHIVls0Hv27J_5UBNwGRVnl2CZmhtr0tIuRn3hoaSN0OOL0_OOTuqlRLrtajNCYhTnXOZ2XYO6q3u48TPIIXsRzAsw8ikQ9KJ7NZI_nUDkJV7jm6oXQUVHx0zX94pu_cqWZC7pZgsWCO5LL_LCXYcamK3DQyZtPj6qkO31LNaiSA9KZtqUercLFvcuov5PD1uuwL59HqSTZ8PneQB6RpivPILfpG0J8Ri6JMxN9-5JXt5M8gbAGjzf17nWDFvMTqK4FfEhRJxvXjgbv7CnyLqEDyywXURgamSSWRUYHoU1qyujIk6EWCWdIX3wUjUpYw2vrUEp7qd0E4mQG58Ki-kh8w4JQ-Ux6qECNZMoXrAzHY-jij7xNRjxpiJwBHSPQcQZ0LMpQGaMbF1dmEE8PuAwbOeKTpdBOsCjgvAzV8RFMP_x7n63_99mD-Ua31Yybt-37bVjwnJLO6rErUBr2v-wO0o2h2i3-qW8n9s4C |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bTuMwEB2xRUL7goBloVz9sEKgrUXtxk7CC7elggWqCoHEW-RbuEik0JaH_j3jxG2F0O4HJJbO2DNnPMczAL-0VcZiaKUuV_7qhjuaSBFRx5XRwmkTa38Ped2R53fR33txH_RPgyCrHPvE0lHbnvF35PscPW2KAUc29_Mgi-j-aR--vlE_QcpXWsM4jW8wi1GxyWswe3LW6d5Mago8FRUZZpwiaY_DE5ryIR1mUdKL2Lx2CIMWlZ_D1Bfu-aVuWoaj9gLMBx5JjivDL8KMK5Zgp1s1oh41yO30XdWgQXZId9qievQDji59df2F7F4_DfvqYVQoUg6i7w3UHrnyUg1yUTwj3AfkmHiX0XePldKdVMWEZbhrn92entMwS4GaViyGFHNm61vT4PltIgeTJnbMCZkmiVV57lhqTZy4vKWtSblKjMwFQyoTYQKppbOi9RNqRa9wq0B8yiGEdJiJ5JFlcaIjpjhmo1YxHUlWh99j6LLXqmVGNmmOXAKdIdBZCXQm67AxRjcLx2eQTY1dh5UK8cmv0GewNBaiDo2xCaYf_nudtf-vsw1zuJ2yq4vO5Tp85z6pLqXZG1Ab9t_dJjKPod4KW-oD8c3SLw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Kratom+%28Mitragyna+Speciosa%29+Liver+Injury%3A+A+Comprehensive+Review&rft.jtitle=Drugs+%28New+York%2C+N.Y.%29&rft.au=Schimmel%2C+Jonathan&rft.au=Dart%2C+Richard+C&rft.date=2020-02-01&rft.pub=Springer+Nature+B.V&rft.issn=0012-6667&rft.eissn=1179-1950&rft.volume=80&rft.issue=3&rft.spage=263&rft.epage=283&rft_id=info:doi/10.1007%2Fs40265-019-01242-6&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-6667&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-6667&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-6667&client=summon |